Karyopharm Therapeutics Inc. Gains 19.83%
Fri, Feb 18, 2022 at 05:30 PM
Karyopharm Therapeutics Inc. (KPTI:NASDAQ) shot up at $14.38, a gain of 19.8%. On Thu, Feb 17, 2022, KPTI:NASDAQ touched a New 2-Week Intraday High of $12.44. The stock appeared on our News Catalysts scanner on Fri, Feb 11, 2022 at 07:21 AM in the 'MISCELLANEOUS' category. From Thu, Feb 03, 2022, the stock recorded 80.00% Up Days and 81.82% Green Days
About Karyopharm Therapeutics Inc. (KPTI:NASDAQ)
Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class drugs directed against nuclear transport and related targets to treat cancer and other diseases.
Top 10 Gainers:
- Sky Harbour Group Corporation Class A (SKYH:NYSEMKT), 48.38%
- RISE Education Cayman Ltd (REDU:NASDAQ), 39.71%
- HOOKIPA Pharma Inc. (HOOK:NASDAQ), 24%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 23.81%
- Amplitude Inc. (AMPL:NASDAQ), 20.82%
- Maris-Tech Ltd. (MTEK:NASDAQ), 20.74%
- Cyngn Inc. (CYN:NASDAQ), 20%
- Karyopharm Therapeutics Inc. (KPTI:NASDAQ), 19.83%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 19.21%
- Flotek Industries, Inc. (FTK:NYSE), 16.3%